Jun 27, 2019 | Articles, ColoPlex, Company Details, Featured, News and Events
By Milt Capps Published June 18, 2019 Comment Print Chairman Tom Boyd, CEO Eric Mayer KNOXVILLE’s EDP Biotech, which was chartered to commercialize assays for early detection of disease and is now focused on its blood-based ColoPlex™ test for colorectal...
Jun 3, 2019 | Articles, ColoPlex, Colorectal Cancer, Featured, News and Events
NEW YORK (GenomeWeb) – In vitro diagnostics developer EDP Biotech said today it has signed a deal with Luminex to develop, market, and sell a blood-based colorectal test using the xMAP technology. Terms of the deal were not disclosed. Called ColoPlex, the inexpensive...
